Skip to content

Clinical trials

Opioid-Induced Constipation trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Induced Constipation Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20062
20077
20082
20092
20105
201110
20122
20133
20141
20161
20172
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated4
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.8
AstraZeneca7
Glycyx Therapeutics6
Shionogi5
Sucampo Pharma Americas, LLC4
Novartis3
Alkermes, Inc.2
BioDelivery Sciences International1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Induced Constipation41
Constipation14
Intestinal Diseases2
Cancer Pain1
Chronic Pain1
Neoplasms1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.